Uncertainty method improved on best-worst case analysis in a binary meta-analysis

被引:115
作者
Gamble, C
Hollis, S
机构
[1] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3GS, Merseyside, England
[2] Univ Lancaster, Med Stat Unit, Lancaster LA1 4YW, England
关键词
meta-analysis; missing data; intention to treat; imputation; uncertainty; randomized controlled trials;
D O I
10.1016/j.jclinepi.2004.09.013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Most systematic reviewers aim to perform an intention-to-treat meta-analysis, including all randomized participants from each trial. This is not straightforward in practice: reviewers must decide how to handle missing outcome data in the contributing trials. Objective: To investigate methods of allowing for uncertainty due to missing data in a meta-analysis. Study Design and Setting: The Cochrane Library was surveyed to assess current use of imputation methods. We developed a methodology for incorporating uncertainty, with weights assigned to trials based on uncertainty interval widths. The uncertainty interval for a trial incorporates both sampling error and the potential impact of missing data. We evaluated the performance of this method using simulated data. Results: The survey showed that complete-case analysis is commonly considered alongside best-worst case analysis. Best-worst case analysis gives an interval for the treatment effect that includes all of the uncertainty due to missing data. Unless there are few missing data, this interval is very wide. Simulations show that the uncertainty method consistently has better power and narrower interval widths than best-worst case analysis. Conclusion: The uncertainty method performs consistently better than best-worst case imputation and should be considered along with complete-case analysis whenever missing data are a concern. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:579 / 588
页数:10
相关论文
共 22 条
[1]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[2]  
Deeks J, 2003, COCHRANE REVIEWERS H
[3]  
DOBSON A, 1997, STAT SCI, V12, P221
[4]  
Dobson A., 1997, STAT SCI, V12, P245
[5]  
EGGER M, 2001, SYSTEMATIC REV HEALT, P302
[6]   Post-randomisation exclusions:: the intention to treat principle and excluding patients from analysis [J].
Fergusson, D ;
Aaron, SD ;
Guyatt, G ;
Hébert, P .
BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7365) :652-654
[7]   METAANALYSIS ADJUSTING FOR COMPLIANCE - THE EXAMPLE OF SCREENING FOR BREAST-CANCER [J].
GLASZIOU, PP .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (11) :1251-1256
[8]  
Heitjan DF, 1999, STAT MED, V18, P2421, DOI 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2421::AID-SIM266>3.3.CO
[9]  
2-I
[10]   What is meant by intention to treat analysis? Survey of published randomised controlled trials [J].
Hollis, S ;
Campbell, F .
BRITISH MEDICAL JOURNAL, 1999, 319 (7211) :670-+